• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Partnerships, Licensing, Investments and M&A Deals and Trends For (12) - 2012 In Pharmaceuticals Product Image

Partnerships, Licensing, Investments and M&A Deals and Trends For (12) - 2012 In Pharmaceuticals

  • ID: 2383169
  • January 2013
  • 64 Pages
  • GlobalData

Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals

Summary

Our “Partnerships, Licensing, Investments and M&A Deals and Trends For December 2012 In Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in December 2012. The report portrays detailed comparative data on the number of deals and their value in the last six months, subdivided by deal types, various therapy areas, and geographies. Additionally, the report provides information on the top financial advisory firms in the pharmaceuticals industry.

Data presented in this report is derived from Our proprietary in-house deals database and primary and secondary research.

Scope

- Analysis of the market trends for the pharmaceutical industry in the global arena.
- Review of deal trends in the cardiovascular, READ MORE >

Note: Product cover images may vary from those shown

1
1

1.1 List of Tables
1.2 List of Figures
2 Pharmaceuticals & Healthcare, Global, Deal Summary,
2.1 Pharmaceuticals & Healthcare, Global, Deal Analysis, December 2012
2.2 Pharmaceuticals & Healthcare, Global, Major Deals, December 2012
2.2.1 Roche Revises Offer Price to Acquire Illumina for Up to $8.2 Billion
2.2.2 Teva Pharma Completes Public Offering of Notes for $2 Billion
2.2.3 HCA Completes Public Offering of Notes Due 2021 for $1 Billion
2.2.4 Mylan Prices Private Placement of Notes Due 2023 for $750 Million
2.2.5 Mitsubishi Chemical to Acquire Qualicaps from Carlyle Group for $660 Million
2.3 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, December 2012
2.4 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, December 2012
3 Pharmaceuticals and Healthcare, Global, Deals, Summary, by Type
3.1 Pharmaceuticals & Healthcare, Global, M&A, December 2012
3.1.1 Top M&A Deals in December 2012
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals by Therapy Area, July 2012-December 2012
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, December 2012
3.2.1 Top Equity Offering Deals in December 2012
3.2.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, July 2012 - December 2012
3.3 Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital Deals, December 2012
3.3.1 Top PE/VC Deals in December 2012
3.3.2 Pharmaceuticals & Healthcare, Global, PE/VC by Therapy Area, December 2012
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, December 2012
3.3.4 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, July 2012 - December 2012
3.3.5 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2012 - December 2012
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, December 2012
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, July 2012 - December 2012
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payments and Deal Values (US$ m), December 2012
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals by Payment Mode, December 2012
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Number Of Deals, July 2012 - December 2012
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, Deal Values (US$ m), July 2012 - December 2012
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012
5.1 Pharmaceuticals & Healthcare, Global, Licensing Agreements, December 2012
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), December 2012
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Deal Value, December 2012
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, December 2012
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements by Total Milestone Payment, December 2012
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Total Deal Values (US$ m), July 2012 - December 2012
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront Payments and Milestone Payments (US$ m), July 2012 - December 2012
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Total Deal Values (US$ m), July 2012 - December 2012
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Upfront Payments and Milestone Payments (US$ m), July 2012 - December 2012
6 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area
6.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, December 2012
6.1.1 Oncology - Deals of the Month
6.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, December 2012
6.2.1 Central Nervous System - Deals of the Month
6.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, December 2012
6.3.1 Infectious Diseases - Deals of the Month
6.4 Pharmaceuticals & Healthcare, Global, Metabolic Disorder Deals, December 2012
6.4.1 Metabolic Disorders - Deal of the Month
6.5 Pharmaceuticals & Healthcare, Global, Immunology Deals, December 2012
6.5.1 Immunology - Deal of the Month
6.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, December 2012
6.6.1 Cardiovascular - Deal of the Month
6.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals, December 2012
6.7.1 Gastrointestinal - Deals of the Month
7 Deal Summary by Geography
7.1 Pharmaceuticals & Healthcare, North America Deals, December 2012
7.1.1 North America - Deals of the Month
7.2 Pharmaceuticals & Healthcare, Europe, Deals, December 2012
7.2.1 Europe - Deals of the Month
7.3 Pharmaceuticals & Healthcare, Asia-Pacific, Regional Deals, December 2012
7.3.1 Asia-Pacific - Deals of the Month
7.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, December 2012
7.4.1 Rest of the World - Deals of the Month
8 Pharmaceuticals & Healthcare, Global, Top Financial Advisors
8.1 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, July 2012 - December 2012
8.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, July 2012 - December 2012
9 Further Information
9.1 Methodology
9.2 About Us
9.3 Contact Us
9.4 Disclosure information
9.5 Disclaimer

1.1 List of Tables
Table 1: Pharmaceuticals & Healthcare, Global, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 2: Pharmaceuticals & Healthcare, Global, Major Deals, December 2012
Table 3: Pharmaceuticals & Healthcare, Global, Number Of Deals and Deal Values (%), December 2012
Table 4: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 5: Pharmaceuticals & Healthcare, Global, Top M&A Deals, December 2012
Table 6: Pharmaceuticals & Healthcare, Global, M&A, Deals Summary, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2012 - December 2012
Table 7: Pharmaceuticals & Healthcare, Global, Equity Offerings, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 8: Pharmaceuticals & Healthcare, Global, Top Equity Offering Deals, December 2012
Table 9: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 10: Pharmaceuticals & Healthcare, Global, PE/VC, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 11: Pharmaceuticals & Healthcare, Global, Top PE/VC Deals, December 2012
Table 12: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Deals Summary, July 2012 - December 2012
Table 13: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number of Deals and Deal Values (%), December 2012
Table 14: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 15: Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, July 2012 - December 2012
Table 16: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 18: Pharmaceuticals & Healthcare, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Table 19: Pharmaceuticals & Healthcare, Global, Partnerships, Upfront and Milestone Payments and Deal Values (US$ m), December 2012
Table 20: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Table 21: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2012 - December 2012
Table 22: Pharmaceuticals & Healthcare, Global, Partnership Deals by Upfront and Milestone Payment and Deal values (US$ m), July 2012 - December 2012
Table 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 24: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Deals Summary, Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Table 25: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Value, December 2012
Table 26: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Upfront Payments, December 2012
Table 27: Pharmaceuticals & Healthcare, Global, Top Licensing Agreement Deals by Total Milestone Payment, December 2012
Table 28: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 29: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments (US$ m), December 2012
Table 30: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2012 - December 2012
Table 31: Pharmaceuticals & Healthcare, Global, Licensing Agreements by Therapy Area, by Upfront and Milestone Payments and Deal Values (US$ m), December 2012
Table 32: Pharmaceuticals & Healthcare, Global, Oncology, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 33: Pharmaceuticals & Healthcare, Global, Central Nervous System, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 34: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 35: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 36: Pharmaceuticals & Healthcare, Global, Immunology, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 37: Pharmaceuticals & Healthcare, Global, Cardiovascular, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 38: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 39: Pharmaceuticals & Healthcare, North America, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 40: Pharmaceuticals & Healthcare, Europe, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 41: Pharmaceuticals & Healthcare, Asia-Pacific, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 42: Pharmaceuticals & Healthcare, Rest of the World, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 43: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Table 44: Pharmaceuticals & Healthcare, Global Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), July 2012 - December 2012

1.2 List of Figures
Figure 1: Pharmaceuticals & Healthcare, Global, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 2: Pharmaceuticals & Healthcare, Global, Number Of Deals (%), December 2012
Figure 3: Pharmaceuticals & Healthcare, Global, Deal Values (%), December 2012
Figure 4: Pharmaceuticals & Healthcare, Global, M&A, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 5: Pharmaceuticals & Healthcare, Global, M&As by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2012 - December 2012
Figure 6: Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 7: Pharmaceuticals & Healthcare, Global, Equity Offering Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 8: Pharmaceuticals & Healthcare, Global, Private Equity and Venture Capital, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 9: Pharmaceuticals & Healthcare, Global, PE/VC Deals by Therapy Area, Number of Deals and Deal Values (US$ m), by Therapy Area, July 2012 - December 2012
Figure 10: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Number Of Deals (%), December 2012
Figure 11: Pharmaceuticals & Healthcare, Global, Venture Capital Deals by Stage of Financing, Deal Values (%), December 2012
Figure 12: Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 13: Pharmaceuticals & Healthcare, Global, Partnerships, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 14: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 15: Pharmaceuticals & Healthcare, Global, Partnership Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Figure 16: Pharmaceuticals & Healthcare, Global, Partnership Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Figure 17: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2012 - December 2012
Figure 18: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, July 2012 - December 2012
Figure 19: Pharmaceuticals & Healthcare, Global, Partnership Deals by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Figure 20: Pharmaceuticals & Healthcare, Global, Licensing Agreements, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 21: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Figure 22: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 23: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Therapy Area, Upfront and Milestone Payments and Deal Values (US$ m), July 2012 - December 2012
Figure 24: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Number Of Deals, July 2012 - December 2012
Figure 25: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, Deal Values (US$ m), July 2012 - December 2012
Figure 26: Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals by Phase, by Upfront and Milestone Payments and Deal Values (US$ m), December 2012
Figure 27: Pharmaceuticals & Healthcare, Global, Oncology, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 28: Pharmaceuticals & Healthcare, Global, Central Nervous System, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 29: Pharmaceuticals & Healthcare, Global, Infectious Diseases, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 30: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 31: Pharmaceuticals & Healthcare, Global, Immunology, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 32: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 33: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 34: Pharmaceuticals & Healthcare, North America, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 35: Pharmaceuticals & Healthcare, Europe, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 36: Pharmaceuticals & Healthcare, Asia-Pacific, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 37: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 38: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), July 2012 - December 2012
Figure 39: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), July 2012 - December 2012

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos